Mariana Girão

Mrs. Mariana Girão

CIIMAR - Interdisciplinary Centre of Marine and Environmental Research, Porto University, Portugal
+1

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
Mariana GirãoMariana Girão
Mariana Girão
IRInês Ribeiro
Inês Ribeiro
TRTiago Ribeiro
Tiago Ribeiro
IAIsabel C. Azevedo
Isabel C. Azevedo
Filipe PereiraFilipe Pereira
Filipe Pereira
MCMaria de Fátima Carvalho
Maria de Fátima Carvalho
Nature is the major reservoir of biologically active molecules. The urgent need of finding novel molecules for pharmaceutical application is prompting the research of underexplored environments, such as marine ecosystems. Here, we investigated cultivable actinobacteria associated with the macroalgae Laminaria ochroleuca and assessed their potential to produce compounds with antimicrobial or anticancer activities. A specimen of L. ochroleuca was collected in a rocky shore in northern Portugal, and fragments of tissues from different parts of the macroalgae (holdfast, stipe, and blades) were surface sterilized and plated in three culture media selective for actinobacteria. A total of 90 actinobacterial strains were isolated, most of which affiliated with the genus Streptomyces. Isolates associated with the genera Isoptericola, Rhodococcus, Nonomuraeae, Nocardiopsis, Microbispora, and Microbacterium were also obtained. Organic extracts from the isolates were tested for their antimicrobial activity using the agar-based disk diffusion method, followed by determination of minimum inhibitory concentration (MIC) values. Forty-five isolates inhibited the growth of Candida albicans and/or Staphylococcus aureus, with MIC values ranging from <0.5 to 1000 μg mL−1. The actinobacterial isolates were also tested for their anticancer potential on two human cancer cell lines. Twenty-eight extracts affected the viability of at least one human cancer cell line (breast carcinoma T-47D and neuroblastoma SH-SY5Y) and non-carcinogenic endothelial cell line (hCMEC/D3). Seven extracts affected the viability of cancer cells only. This study revealed that L. ochroleuca is a rich source of actinobacteria with promising antimicrobial and anticancer activities and suggests that macroalgae may be a valuable source of actinobacteria and, consequently, of new molecules with biotechnological importance.

30 October 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
IRInês Ribeiro
Inês Ribeiro
Mariana GirãoMariana Girão
Mariana Girão
DADiogo Alexandrino
Diogo Alexandrino
TRTiago Ribeiro
Tiago Ribeiro
CSChiara Santos
Chiara Santos
MCMaria de Fátima Carvalho
Maria de Fátima Carvalho
Natural compounds have had increasing applications in the biotechnological sector, with a large fraction of these substances being channeled to the pharmaceutical industry due to their important pharmacological properties. The discovery of new bioactive molecules with novel mechanisms of action constitutes a promising solution for the design of alternative therapeutic solutions. Actinobacteria are a large group of morphologically and physiologically diverse bacteria well known for their production of biotechnologically relevant compounds. The Portuguese coast is scantly explored in terms of Actinobacteria diversity and respective bioactive potential, offering a good opportunity to find new Actinobacteria taxa and bioactive natural products. In this study, we investigated the Actinobacteria diversity associated with a sediment sample collected from the intertidal zone of a beach in northern Portugal, through a cultivation-dependent approach, and screened its antimicrobial and cytotoxic potential. A total of 52 Actinobacteria strains were recovered from the marine sediment, with the largest fraction of the isolates belonging to the genus Micromonospora. Bioactivity screening assays identified crude extracts of six Streptomyces strains active against C. albicans, exhibiting minimum inhibition concentration (MIC) values in the range of 3.90–125 μg mL−1. Twenty-five Actinobacteria crude extracts (obtained from strains of the genera Micromonospora, Streptomyces and Actinomadura) exhibited significant effects on the viability of at least one tested cancer cell line (breast ductal carcinoma T-47D and liver hepatocellular carcinoma HepG2). The Actinobacteria extracts demonstrating activity in the antimicrobial and/or cytotoxic assays were subjected to metabolomic analysis (Mass spectrometry (MS)-based dereplication and molecular networking analyses), indicating the presence of four clusters that may represent new natural products. The results obtained demonstrate the importance of bioprospecting underexplored environments, like the Portuguese coast, for enhancing the discovery of new natural products, and call attention to the relevance of preserving the natural genetic diversity of coastal environments.

21 March 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
Mariana GirãoMariana Girão
Mariana Girão
SFSara Freitas
Sara Freitas
TMTeresa P. Martins
Teresa P. Martins
RURalph Urbatzka
Ralph Urbatzka
MCMaria F. Carvalho
Maria F. Carvalho
PLPedro N. Leão
Pedro N. Leão
Bioprospecting actinobacterial secondary metabolism from untapped marine sources may lead to the discovery of biotechnologically-relevant compounds. While studying the diversity and bioactive potential of Actinomycetota associated with Codium tomentosum, a green seaweed collected in the northern Portuguese cost, strain CT-F61, identified as Streptomyces violaceoruber, was isolated. Its extracts displayed a strong anticancer activity on breast carcinoma T-47D and colorectal carcinoma HCT116 cells, being effective as well against a panel of human and fish pathogenic bacteria. Following a bioactivity-guided isolation pipeline, a new analogue of the red-pigmented family of the antibiotics prodigiosins, decylprodigiosin (1), was identified and chemically characterized. Despite this family of natural products being well-known for a long time, we report a new analogue and the first evidence for prodigiosins being produced by a seaweed-associated actinomycete.

16 April 2024 in Environmental Microbiology
Verified
Journal Article
Open access
Mariana GirãoMariana Girão
Mariana Girão
DADiogo Alexandrino
Diogo Alexandrino
WCWeiwei Cao
Weiwei Cao
ICIsabel Costa
Isabel Costa
ZJZhongjun Jia
Zhongjun Jia
MCMaria F. Carvalho
Maria F. Carvalho
Actinomycetota, associated with macroalgae, remains one of the least explored marine niches. The secondary metabolism of Actinomycetota, the primary microbial source of compounds relevant to biotechnology, continues to drive research into the distribution, dynamics, and metabolome of these microorganisms. In this study, we employed a combination of traditional cultivation and metagenomic analysis to investigate the diversity of Actinomycetota in two native macroalgae species from the Portuguese coast. We obtained and taxonomically identified a collection of 380 strains, which were distributed across 12 orders, 15 families, and 25 genera affiliated with the Actinomycetia class, with Streptomyces making up approximately 60% of the composition. Metagenomic results revealed the presence of Actinomycetota in both Chondrus crispus and Codium tomentosum datasets, with relative abundances of 11% and 2%, respectively. This approach identified 12 orders, 16 families, and 17 genera affiliated with Actinomycetota, with minimal overlap with the cultivation results. Acidimicrobiales emerged as the dominant actinobacterial order in both macroalgae, although no strain affiliated with this taxonomic group was successfully isolated. Our findings suggest that macroalgae represent a hotspot for Actinomycetota. The synergistic use of both culture‐dependent and independent approaches proved beneficial, enabling the identification and recovery of not only abundant but also rare taxonomic members.


18 December 2024 in Microbial Biotechnology
Verified
Journal Article
Open access
Mariana GirãoMariana Girão
Mariana Girão
ARAdriana Rego
Adriana Rego
AFAna C. Fonseca
Ana C. Fonseca
WCWeiwei Cao
Weiwei Cao
ZJZhongjun Jia
Zhongjun Jia
MCMaria de Fátima Carvalho
Maria de Fátima Carvalho
Actinomycetota are unrivalled producers of bioactive natural products, with strains living in association with macroalgae representing a prolific—yet largely unexplored—source of specialised chemicals. In this work, we have investigated the bioactive potential of Actinomycetota from macroalgae through culture‐dependent and ‐independent approaches. A bioprospecting pipeline was applied to a collection of 380 actinobacterial strains, recovered from two macroalgae species collected in the Portuguese northern shore— Codium tomentosum and Chondrus crispus— in order to explore their ability to produce antibacterial, antifungal, anticancer and lipid‐reducing compounds. Around 43% of the crude extracts showed activity in at least one of the screenings performed: 111 presented antimicrobial activity at 1 mg/mL, 83 significantly decreased cancer cells viability at 15 μg/mL and 5 reduced lipid content in zebrafish > 60% at 15 ug/mL. Dereplication of active extracts unveiled the presence of compounds that could explain most of the recorded results, but also unknown molecules in the metabolome of several strains, highlighting the opportunity for discovery. The bioactive potential of the actinobacterial community from the same macroalgae specimens, which served as the source for the aforementioned Actinomycetota collection, was also explored through metagenomics analysis, allowing to obtain a broader picture of its functional diversity and novelty. A total of 133 biosynthetic gene clusters recovered from metagenomic contigs and metagenome assembled genomes (MAGs). These were grouped into 91 gene cluster families, 83 of which shared less than 30% of similarity to database entries. Our findings provided by culture‐dependent and ‐independent approaches underscore the potential held by actinomycetes from macroalgae as reservoirs for novel bioactive natural products.